Alcidion Group Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Alcidion Group wird ein jährliches Gewinn- und Umsatzwachstum von 67.2% bzw. 5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 69.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 0.1% betragen.

Wichtige Informationen

67.2%

Wachstumsrate der Gewinne

69.2%

EPS-Wachstumsrate

Healthcare Services Gewinnwachstum	24.1%
Wachstumsrate der Einnahmen	5.0%
Zukünftige Eigenkapitalrendite	0.1%
Analystenabdeckung	Low
Zuletzt aktualisiert	18 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet

Jun 14

We're Hopeful That Alcidion Group (ASX:ALC) Will Use Its Cash Wisely

Apr 24

Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding

Jan 30

Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being

Nov 13

Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth

Oct 19

We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow

Jul 17

Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?

Jun 02

Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates

Feb 25

Gewinn- und Umsatzwachstumsprognosen

ASX:ALC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2026	45	-1	N/A	3	2
6/30/2025	42	-1	3	2	3
6/30/2024	39	-6	-3	-4	3
12/31/2023	40	-5	-7	-6	N/A
9/30/2023	40	-4	-3	-3	N/A
6/30/2023	40	-4	0	0	N/A
3/31/2023	40	-2	-1	-1	N/A
12/31/2022	40	-1	-3	-2	N/A
9/30/2022	37	-3	-1	-1	N/A
6/30/2022	34	-4	1	1	N/A
3/31/2022	31	-6	2	2	N/A
12/31/2021	28	-7	2	3	N/A
9/30/2021	27	-5	2	2	N/A
6/30/2021	26	-2	1	2	N/A
3/31/2021	24	-2	-1	-1	N/A
12/31/2020	22	-3	-4	-4	N/A
9/30/2020	20	-3	-3	-3	N/A
6/30/2020	19	-3	-2	-2	N/A
3/31/2020	18	-2	-1	-1	N/A
12/31/2019	18	-1	0	0	N/A
9/30/2019	17	-1	1	1	N/A
6/30/2019	17	0	2	2	N/A
3/31/2019	13	-1	0	0	N/A
12/31/2018	10	-2	-1	-1	N/A
9/30/2018	7	-2	-2	-1	N/A
6/30/2018	4	-2	-2	-2	N/A
3/31/2018	4	-2	-2	-2	N/A
12/31/2017	3	-2	-1	-1	N/A
9/30/2017	3	-2	N/A	-1	N/A
6/30/2017	3	-2	N/A	-1	N/A
3/31/2017	4	-3	N/A	-1	N/A
12/31/2016	4	-3	N/A	-2	N/A
9/30/2016	4	-3	N/A	-2	N/A
6/30/2016	4	-3	N/A	-3	N/A
6/30/2015	5	0	N/A	1	N/A
6/30/2014	2	-1	N/A	N/A	N/A
6/30/2013	5	0	N/A	N/A	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ALC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: ALC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: ALC wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: ALCDie Einnahmen des Unternehmens (5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Australian (5% pro Jahr).

Hohe Wachstumseinnahmen: ALCDie Einnahmen des Unternehmens (5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ALCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (0.1 %).

Alcidion Group Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024

Consensus revenue estimates fall by 12%

Consensus EPS estimates fall by 17%

Price target decreased by 12% to AU$0.097

Consensus EPS estimates fall by 315%

Price target decreased by 15% to AU$0.14

Recent updates

Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet

We're Hopeful That Alcidion Group (ASX:ALC) Will Use Its Cash Wisely

Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024

Alcidion Group Limited to Report Q3, 2024 Results on Apr 18, 2024

New minor risk - Profitability

Consensus revenue estimates fall by 12%

Alcidion Group Limited to Report First Half, 2024 Results on Feb 28, 2024

Consensus EPS estimates fall by 17%

Price target decreased by 12% to AU$0.097

Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding

Alcidion Group Limited to Report Q2, 2024 Results on Jan 31, 2024

Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being

Alcidion Group Limited has completed a Follow-on Equity Offering in the amount of AUD 5.025 million.

New minor risk - Shareholder dilution

Alcidion Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million.

Consensus EPS estimates fall by 315%

Price target decreased by 15% to AU$0.14

Alcidion Group Limited to Report Q1, 2024 Results on Oct 31, 2023

Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth

Alcidion Group Limited, Annual General Meeting, Nov 20, 2023

Consensus EPS estimates fall from profit to AU$0.0003 loss

Now 25% undervalued

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Alcidion Group Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Consensus EPS estimates upgraded to AU$0.0031 loss

Alcidion Group Limited to Report Q4, 2023 Results on Jul 27, 2023

Now 21% undervalued after recent price drop

We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow

Price target decreased by 17% to AU$0.17

Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?

Independent Non-Executive Director recently bought AU$55k worth of stock

Forecast breakeven date moved forward to 2023

Forecast breakeven date pushed back to 2024

Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in 1H 2022)

Alcidion Group Limited to Report First Half, 2023 Results on Feb 24, 2023

Alcidion Group Limited to Report First Half, 2023 Results on Jan 30, 2023

Now 22% undervalued

Price target increased to AU$0.20

When Should You Buy Alcidion Group Limited (ASX:ALC)?

Alcidion Group Limited Announces Malcolm Pradhan Stepping Down as Executive Director and Chief Medical Officer

Alcidion Group Limited to Report Q1, 2023 Results on Oct 31, 2022

Full year 2022 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in FY 2021)

Alcidion Group Limited, Annual General Meeting, Oct 25, 2022

Alcidion Group Limited to Report Fiscal Year 2022 Results on Aug 30, 2022

Alcidion Group Limited to Report Q4, 2022 Results on Jul 27, 2022

Price target decreased to AU$0.32

Forecast breakeven date pushed back to 2023

Alcidion Group Limited to Report Q3, 2022 Results on Apr 27, 2022

Price target decreased to AU$0.32

Forecast breakeven date pushed back to 2023

First half 2022 earnings: EPS and revenues exceed analyst expectations

Alcidion Group Limited to Report First Half, 2022 Results on Feb 23, 2022

Price target decreased to AU$0.40

Alcidion Group Limited (ASX:ALC) completed the acquisition of Silverlink Software Limited.

Alcidion Group Limited (ASX:ALC) agreed to acquire Silverlink Software Limited for £33 million.

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Alcidion Group Limited Provides Earnings Guidance for the Fiscal 2022

Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020)

Consensus EPS estimates increase to -AU$0.0005

Co-Founder & Non-Executive Director Raymond Blight has left the company

Insider recently bought AU$3.9m worth of stock

Price target increased to AU$0.43

When Will Alcidion Group Limited (ASX:ALC) Breakeven?

Calculating The Fair Value Of Alcidion Group Limited (ASX:ALC)